A detailed history of Emprise Bank transactions in Merck & Co., Inc. stock. As of the latest transaction made, Emprise Bank holds 7,608 shares of MRK stock, worth $751,822. This represents 0.43% of its overall portfolio holdings.

Number of Shares
7,608
Previous 9,365 18.76%
Holding current value
$751,822
Previous $1.06 Billion 28.83%
% of portfolio
0.43%
Previous 0.61%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$96.31 - $114.76 $169,216 - $201,633
-1,757 Reduced 18.76%
7,608 $757 Million
Q3 2024

Oct 01, 2024

SELL
$111.15 - $128.97 $195,957 - $227,374
-1,763 Reduced 15.84%
9,365 $1.06 Billion
Q2 2024

Jul 29, 2024

BUY
$123.8 - $132.96 $61,528 - $66,081
497 Added 4.68%
11,128 $1.38 Billion
Q1 2024

Apr 08, 2024

BUY
$113.24 - $131.95 $1.2 Million - $1.4 Million
10,631 New
10,631 $1.4 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Emprise Bank Portfolio

Follow Emprise Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emprise Bank, based on Form 13F filings with the SEC.

News

Stay updated on Emprise Bank with notifications on news.